{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T14:49:39Z","timestamp":1792594179665,"version":"4.5.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,8,28]]},"DOI":"10.7759\/cureus.44260","type":"journal-article","created":{"date-parts":[[2023,8,28]],"date-time":"2023-08-28T14:46:55Z","timestamp":1693234015000},"source":"Crossref","is-referenced-by-count":12,"title":["Acute Intermittent Porphyria: A Review and Rehabilitation Perspective"],"prefix":"10.7759","author":[{"given":"Adriana","family":"Valbuena Valecillos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Puja","family":"Yatham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matison","family":"Alderman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Shapiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduard","family":"Tiozzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joslyn","family":"Gober","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Porphyrias. (2022). Accessed. April 11, 2023: https:\/\/rarediseases.org\/rare-diseases\/porphyria\/."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awn152","article-title":"Nerve function and dysfunction in acute intermittent porphyria","volume":"131","author":"Lin CS","year":"2008","unstructured":"Lin CS, Krishnan AV, Lee MJ, et al.. Nerve function and dysfunction in acute intermittent porphyria. Brain. 2008, 131:2510-9. 10.1093\/brain\/awn152","journal-title":"Brain"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/jimd.12612","article-title":"Key terms and definitions in acute porphyrias: results of an international Delphi consensus led by the European porphyria network","volume":"46","author":"Stein PE","year":"2023","unstructured":"Stein PE, Edel Y, Mansour R, Mustafa RA, Sandberg S. Key terms and definitions in acute porphyrias: results of an international Delphi consensus led by the European porphyria network. J Inherit Metab Dis. 2023, 46:662-74. 10.1002\/jimd.12612","journal-title":"J Inherit Metab Dis"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.2389","article-title":"Acute porphyrias - a neurological perspective","volume":"11","author":"Gerischer LM","year":"2021","unstructured":"Gerischer LM, Scheibe F, N\u00fcmann A, K\u00f6hnlein M, St\u00f6lzel U, Meisel A. Acute porphyrias - a neurological perspective. Brain Behav. 2021, 11:e2389. 10.1002\/brb3.2389","journal-title":"Brain Behav"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1159\/000496420","article-title":"Acute intermittent porphyria: a report of 3 cases with neuropathy","volume":"11","author":"Alqwaifly M","year":"2019","unstructured":"Alqwaifly M, Bril V, Dodig D. Acute intermittent porphyria: a report of 3 cases with neuropathy. Case Rep Neurol. 2019, 11:32-6. 10.1159\/000496420","journal-title":"Case Rep Neurol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.2147\/TCRM.S180161","article-title":"Acute intermittent porphyria: current perspectives and case presentation","volume":"15","author":"Spiritos Z","year":"2019","unstructured":"Spiritos Z, Salvador S, Mosquera D, Wilder J. Acute intermittent porphyria: current perspectives and case presentation. Ther Clin Risk Manag. 2019, 15:1443-51. 10.2147\/TCRM.S180161","journal-title":"Ther Clin Risk Manag"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/humu.23067","article-title":"Acute intermittent porphyria: predicted pathogenicity of HMBS variants indicates extremely low penetrance of the autosomal dominant disease","volume":"37","author":"Chen B","year":"2016","unstructured":"Chen B, Solis-Villa C, Hakenberg J, et al.. Acute intermittent porphyria: predicted pathogenicity of HMBS variants indicates extremely low penetrance of the autosomal dominant disease. Hum Mutat. 2016, 37:1215-22. 10.1002\/humu.23067","journal-title":"Hum Mutat"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.5582\/irdr.2020.03082","article-title":"Recent advances in the epidemiology and genetics of acute intermittent porphyria","volume":"9","author":"Ma L","year":"2020","unstructured":"Ma L, Tian Y, Peng C, Zhang Y, Zhang S. Recent advances in the epidemiology and genetics of acute intermittent porphyria. Intractable Rare Dis Res. 2020, 9:196-204. 10.5582\/irdr.2020.03082","journal-title":"Intractable Rare Dis Res"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s00439-013-1358-4","article-title":"The Human Gene Mutation Database: building a comprehensive mutation repository for clinical and molecular genetics, diagnostic testing and personalized genomic medicine","volume":"133","author":"Stenson PD","year":"2014","unstructured":"Stenson PD, Mort M, Ball EV, Shaw K, Phillips A, Cooper DN. The Human Gene Mutation Database: building a comprehensive mutation repository for clinical and molecular genetics, diagnostic testing and personalized genomic medicine. Hum Genet. 2014, 133:1-9. 10.1007\/s00439-013-1358-4","journal-title":"Hum Genet"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1080\/003655100300054891","article-title":"The W198X and R173W mutations in the porphobilinogen deaminase gene in acute intermittent porphyria have higher clinical penetrance than R167W. A population-based study","volume":"60","author":"Andersson C","year":"2000","unstructured":"Andersson C, Floderus Y, Wikberg A, Lithner F. The W198X and R173W mutations in the porphobilinogen deaminase gene in acute intermittent porphyria have higher clinical penetrance than R167W. A population-based study. Scand J Clin Lab Invest. 2000, 60:643-8. 10.1080\/003655100300054891","journal-title":"Scand J Clin Lab Invest"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-012-9544-4","article-title":"The incidence of inherited porphyrias in Europe","volume":"36","author":"Elder G","year":"2013","unstructured":"Elder G, Harper P, Badminton M, Sandberg S, Deybach JC. The incidence of inherited porphyrias in Europe. J Inherit Metab Dis. 2013, 36:849-57. 10.1007\/s10545-012-9544-4","journal-title":"J Inherit Metab Dis"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddy030","article-title":"From a dominant to an oligogenic model of inheritance with environmental modifiers in acute intermittent porphyria","volume":"27","author":"Lenglet H","year":"2018","unstructured":"Lenglet H, Schmitt C, Grange T, et al.. From a dominant to an oligogenic model of inheritance with environmental modifiers in acute intermittent porphyria. Hum Mol Genet. 2018, 27:1164-73. 10.1093\/hmg\/ddy030","journal-title":"Hum Mol Genet"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/0891-5849(95)02035-7","article-title":"The prooxidant effect of 5-aminolevulinic acid in the brain tissue of rats: Implications in neuropsychiatric manifestations in porphyrias","volume":"20","author":"Demasi M","year":"1996","unstructured":"Demasi M, Penatti CA, DeLucia R, Bechara EJ. The prooxidant effect of 5-aminolevulinic acid in the brain tissue of rats: Implications in neuropsychiatric manifestations in porphyrias. Free Radic Biol Med. 1996, 20:291-9. 10.1016\/0891-5849(95)02035-7","journal-title":"Free Radic Biol Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.7196\/SAMJ.2016.v106i1.10118","article-title":"Severe porphyric neuropathy--importance of screening for porphyria in Guillain-Barr\u00e9 syndrome","volume":"106","author":"Schutte CM","year":"2015","unstructured":"Schutte CM, van der Meyden CH, van Niekerk L, Kakaza M, van Coller R, Ueckermann V, Oosthuizen NM. Severe porphyric neuropathy--importance of screening for porphyria in Guillain-Barr\u00e9 syndrome. S Afr Med J. 2015, 106:44-7. 10.7196\/SAMJ.2016.v106i1.10118","journal-title":"S Afr Med J"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-019-1031-7","article-title":"High penetrance of acute intermittent porphyria in a Spanish founder mutation population and CYP2D6 genotype as a susceptibility factor","volume":"14","author":"Barreda-S\u00e1nchez M","year":"2019","unstructured":"Barreda-S\u00e1nchez M, Buend\u00eda-Mart\u00ednez J, Glover-L\u00f3pez G, et al.. High penetrance of acute intermittent porphyria in a Spanish founder mutation population and CYP2D6 genotype as a susceptibility factor. Orphanet J Rare Dis. 2019, 14:59. 10.1186\/s13023-019-1031-7","journal-title":"Orphanet J Rare Dis"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/BF00975044","article-title":"Delta-aminolevulinic acid effects on neuronal and glial tumor cell lines","volume":"18","author":"Helson L","year":"1993","unstructured":"Helson L, Braverman S, Mangiardi J. Delta-aminolevulinic acid effects on neuronal and glial tumor cell lines. Neurochem Res. 1993, 18:1255-8. 10.1007\/BF00975044","journal-title":"Neurochem Res"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.21037\/tgh-2020-01","article-title":"The acute hepatic porphyrias","volume":"6","author":"Wang B","year":"2021","unstructured":"Wang B. The acute hepatic porphyrias. Transl Gastroenterol Hepatol. 2021, 6:24. 10.21037\/tgh-2020-01","journal-title":"Transl Gastroenterol Hepatol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1002\/mus.27232","article-title":"Porphyric neuropathy","volume":"64","author":"Gandhi Mehta RK","year":"2021","unstructured":"Gandhi Mehta RK, Caress JB, Rudnick SR, Bonkovsky HL. Porphyric neuropathy. Muscle Nerve. 2021, 64:140-52. 10.1002\/mus.27232","journal-title":"Muscle Nerve"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.48.6.1678","article-title":"Acute intermittent porphyria: clinicopathologic correlation. Report of a case and review of the literature","volume":"48","author":"Suarez JI","year":"1997","unstructured":"Suarez JI, Cohen ML, Larkin J, Kernich CA, Hricik DE, Daroff RB. Acute intermittent porphyria: clinicopathologic correlation. Report of a case and review of the literature. Neurology. 1997, 48:1678-83. 10.1212\/wnl.48.6.1678","journal-title":"Neurology"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1170\/T841","article-title":"Neurological manifestations of acute intermittent porphyria","volume":"55","author":"Pischik E","year":"2009","unstructured":"Pischik E, Kauppinen R. Neurological manifestations of acute intermittent porphyria. Cell Mol Biol (Noisy-le-grand). 2009, 55:72-83. 10.1170\/T841","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1002\/hep4.1297","article-title":"Acute hepatic porphyrias: review and recent progress","volume":"3","author":"Wang B","year":"2019","unstructured":"Wang B, Rudnick S, Cengia B, Bonkovsky HL. Acute hepatic porphyrias: review and recent progress. Hepatol Commun. 2019, 3:193-206. 10.1002\/hep4.1297","journal-title":"Hepatol Commun"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1002\/mus.20137","article-title":"Porphyric neuropathy","volume":"30","author":"Albers JW","year":"2004","unstructured":"Albers JW, Fink JK. Porphyric neuropathy. Muscle Nerve. 2004, 30:410-22. 10.1002\/mus.20137","journal-title":"Muscle Nerve"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1007\/s11910-020-01089-5","article-title":"Correction to: porphyric neuropathy: pathophysiology, diagnosis, and updated management","volume":"21","author":"Kazamel M","year":"2020","unstructured":"Kazamel M, Desnick RJ, Quigley JG. Correction to: porphyric neuropathy: pathophysiology, diagnosis, and updated management. Curr Neurol Neurosci Rep. 2020, 21:1. 10.1007\/s11910-020-01089-5","journal-title":"Curr Neurol Neurosci Rep"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000009838","article-title":"Pearls & oy-sters: Guillain-Barr\u00e9 syndrome: an unusual presentation of acute intermittent porphyria","volume":"95","author":"Ponciano A","year":"2020","unstructured":"Ponciano A, Carvalho JN, Gala D, Leite J, Fernandes C. Pearls & oy-sters: Guillain-Barr\u00e9 syndrome: an unusual presentation of acute intermittent porphyria. Neurology. 2020, 95:e1437-40. 10.1212\/WNL.0000000000009838","journal-title":"Neurology"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.2147\/TACG.S48605","article-title":"An update of clinical management of acute intermittent porphyria","volume":"8","author":"Pischik E","year":"2015","unstructured":"Pischik E, Kauppinen R. An update of clinical management of acute intermittent porphyria. Appl Clin Genet. 2015, 8:201-14. 10.2147\/TACG.S48605","journal-title":"Appl Clin Genet"},{"key":"ref26","unstructured":"The drug database for acute porphyria. (2023). Accessed. April 11, 2023: http:\/\/www.drugs-porphyria.org\/."},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.3109\/00016349709047833","article-title":"Acute intermittent porphyria precipitated by hyperemesis and metoclopramide treatment in pregnancy","volume":"76","author":"Shenhav S","year":"1997","unstructured":"Shenhav S, Gemer O, Sassoon E, Segal S. Acute intermittent porphyria precipitated by hyperemesis and metoclopramide treatment in pregnancy. Acta Obstet Gynecol Scand. 1997, 76:484-5. 10.3109\/00016349709047833","journal-title":"Acta Obstet Gynecol Scand"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.4097\/kjae.2014.67.3.217","article-title":"Severe neurologic manifestations in acute intermittent porphyria developed after spine surgery under general anesthesia: a case report","volume":"67","author":"Park EY","year":"2014","unstructured":"Park EY, Kim YS, Lim KJ, Lee HK, Lee SK, Choi H, Kang MH. Severe neurologic manifestations in acute intermittent porphyria developed after spine surgery under general anesthesia: a case report. Korean J Anesthesiol. 2014, 67:217-20. 10.4097\/kjae.2014.67.3.217","journal-title":"Korean J Anesthesiol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1136\/gut.35.8.1112","article-title":"Safety of general anaesthesia and surgery in acute hepatic porphyria","volume":"35","author":"Dover SB","year":"1994","unstructured":"Dover SB, Plenderleith L, Moore MR, McColl KE. Safety of general anaesthesia and surgery in acute hepatic porphyria. Gut. 1994, 35:1112-5. 10.1136\/gut.35.8.1112","journal-title":"Gut"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1608634","article-title":"Porphyria","volume":"377","author":"Bissell DM","year":"2017","unstructured":"Bissell DM, Anderson KE, Bonkovsky HL. Porphyria. N Engl J Med. 2017, 377:862-72. 10.1056\/NEJMra1608634","journal-title":"N Engl J Med"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1007\/s11910-022-01205-7","article-title":"Neurological manifestations of acute porphyrias","volume":"22","author":"Wylie K","year":"2022","unstructured":"Wylie K, Testai FD. Neurological manifestations of acute porphyrias. Curr Neurol Neurosci Rep. 2022, 22:355-62. 10.1007\/s11910-022-01205-7","journal-title":"Curr Neurol Neurosci Rep"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-021-01511-3","article-title":"Givosiran: a review in acute hepatic porphyria","volume":"81","author":"Syed YY","year":"2021","unstructured":"Syed YY. Givosiran: a review in acute hepatic porphyria. Drugs. 2021, 81:841-8. 10.1007\/s40265-021-01511-3","journal-title":"Drugs"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199602223340803","article-title":"A reversible posterior leukoencephalopathy syndrome","volume":"334","author":"Hinchey J","year":"1996","unstructured":"Hinchey J, Chaves C, Appignani B, et al.. A reversible posterior leukoencephalopathy syndrome. N Engl J Med. 1996, 334:494-500. 10.1056\/NEJM199602223340803","journal-title":"N Engl J Med"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000011665","article-title":"Acute intermittent porphyria presenting with seizures and posterior reversible encephalopathy syndrome: two case reports and a literature review","volume":"97","author":"Zheng X","year":"2018","unstructured":"Zheng X, Liu X, Wang Y, et al.. Acute intermittent porphyria presenting with seizures and posterior reversible encephalopathy syndrome: two case reports and a literature review. Medicine (Baltimore). 2018, 97:e11665. 10.1097\/MD.0000000000011665","journal-title":"Medicine (Baltimore)"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1016\/j.jfma.2013.04.011","article-title":"Treatment of neuropathic pain in acute intermittent porphyria with gabapentin","volume":"112","author":"Lin TC","year":"2013","unstructured":"Lin TC, Lai SL, Hsu SP, Ro LS. Treatment of neuropathic pain in acute intermittent porphyria with gabapentin. J Formos Med Assoc. 2013, 112:578-9. 10.1016\/j.jfma.2013.04.011","journal-title":"J Formos Med Assoc"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)61925-5","article-title":"Porphyrias","volume":"375","author":"Puy H","year":"2010","unstructured":"Puy H, Gouya L, Deybach JC. Porphyrias. Lancet. 2010, 375:924-37. 10.1016\/S0140-6736(09)61925-5","journal-title":"Lancet"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgmr.2022.100842","article-title":"Long-term follow-up of acute porphyria in female patients: update of clinical outcome and life expectancy","volume":"30","author":"Baumann K","year":"2022","unstructured":"Baumann K, Kauppinen R. Long-term follow-up of acute porphyria in female patients: update of clinical outcome and life expectancy. Mol Genet Metab Rep. 2022, 30:100842. 10.1016\/j.ymgmr.2022.100842","journal-title":"Mol Genet Metab Rep"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.4103\/0974-2700.136847","article-title":"Acute flaccid paralysis in adults: our experience","volume":"7","author":"Kaushik R","year":"2014","unstructured":"Kaushik R, Kharbanda PS, Bhalla A, Rajan R, Prabhakar S. Acute flaccid paralysis in adults: our experience. J Emerg Trauma Shock. 2014, 7:149-54. 10.4103\/0974-2700.136847","journal-title":"J Emerg Trauma Shock"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2019.10.011","article-title":"Porphyria-induced posterior reversible encephalopathy syndrome and central nervous system dysfunction","volume":"128","author":"Jaramillo-Calle DA","year":"2019","unstructured":"Jaramillo-Calle DA, Solano JM, Rabinstein AA, Bonkovsky HL. Porphyria-induced posterior reversible encephalopathy syndrome and central nervous system dysfunction. Mol Genet Metab. 2019, 128:242-53. 10.1016\/j.ymgme.2019.10.011","journal-title":"Mol Genet Metab"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1007\/s11910-020-01078-8","article-title":"Porphyric neuropathy: pathophysiology, diagnosis, and updated management","volume":"20","author":"Kazamel M","year":"2020","unstructured":"Kazamel M, Desnick RJ, Quigley JG. Porphyric neuropathy: pathophysiology, diagnosis, and updated management. Curr Neurol Neurosci Rep. 2020, 20:56. 10.1007\/s11910-020-01078-8","journal-title":"Curr Neurol Neurosci Rep"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1097\/PHM.0000000000000590","article-title":"A comprehensive rehabilitation program and follow-up assessment for acute intermittent porphyria","volume":"96","author":"Bonnefoy Mirralles AM","year":"2017","unstructured":"Bonnefoy Mirralles AM, Torres-Castro R, Ovalle Guzman C. A comprehensive rehabilitation program and follow-up assessment for acute intermittent porphyria. Am J Phys Med Rehabil. 2017, 96:e85-8. 10.1097\/PHM.0000000000000590","journal-title":"Am J Phys Med Rehabil"},{"key":"ref42","unstructured":"Fiscal Year (FY) 2021 Inpatient Rehabilitation Facility (IRF) Prospective Payment System (PPS) (CMS-1729-F). (2020). https.\/\/www.cms.gov\/newsroom\/fact-sheets\/fiscal-year-fy-2021-inpatient-rehabilitation-facility-irf-prospective-paymen...."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/172498-acute-intermittent-porphyria-a-review-and-rehabilitation-perspective","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:55:16Z","timestamp":1707508516000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/172498-acute-intermittent-porphyria-a-review-and-rehabilitation-perspective"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,28]]},"references-count":42,"URL":"https:\/\/doi.org\/10.7759\/cureus.44260","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8,28]]}}}